Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health
Investment will fund genomics startups for Illumina Accelerator Cambridge graduates
05-Jul-2022 -
Illumina, Inc. announced its participation in Time Boost Capital I LP, a £30 million genomics venture fund dedicated to providing match funding to startups graduating from Illumina Accelerator Cambridge with the aim to advance breakthroughs in human health. Illumina Accelerator, located in both ...
genomics
investments
precision medicine
+1